Correlation Between Enveric Biosciences and Elevation Oncology

Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enveric Biosciences and Elevation Oncology, you can compare the effects of market volatilities on Enveric Biosciences and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Elevation Oncology.

Diversification Opportunities for Enveric Biosciences and Elevation Oncology

0.17

Correlation Coefficient

Enveric Biosciences  Elevation Oncology

Average diversification

The 3 months correlation between Enveric and Elevation is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Elevation Oncology go up and down completely randomly.

Pair Corralation between Enveric Biosciences and Elevation Oncology

Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Elevation Oncology. In addition to that, Enveric Biosciences is 2.59 times more volatile than Elevation Oncology. It trades about -0.44 of its total potential returns per unit of risk. Elevation Oncology is currently generating about -0.05 per unit of volatility. If you would invest  71.00  in Elevation Oncology on November 19, 2024 and sell it today you would lose (3.80) from holding Elevation Oncology or give up 5.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Enveric Biosciences  vs.  Elevation Oncology

Enveric Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Elevation Oncology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enveric Biosciences and Elevation Oncology

The main advantage of trading using opposite Enveric Biosciences and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.

The idea behind Enveric Biosciences and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.